Antidepressants may have to fight for Part D coverage

Share this article:

The Centers for Medicare and Medicaid Services (CMS) is proposing a new Part D access rule for immunosuppressants and antidepressants that would no longer require every drug in every class to have a place on the formulary, BioCentury reports. These two drug classes have been part of what's considered a protected class in Medicare Part D, a category which includes anticonvulsants, antineoplastics, antipsychotics and antiretrovirals.

The proposed rule says the remaining four classes would still be protected. The proposed change could give payers more leverage in rebate negotiations with pharmaceutical firms—insurers have claimed, the rule notes, that the protected status means companies have no incentive to lower prices because the current rule secures Part D formulary status.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.